ATE167187T1 - Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents

Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE167187T1
ATE167187T1 AT92918526T AT92918526T ATE167187T1 AT E167187 T1 ATE167187 T1 AT E167187T1 AT 92918526 T AT92918526 T AT 92918526T AT 92918526 T AT92918526 T AT 92918526T AT E167187 T1 ATE167187 T1 AT E167187T1
Authority
AT
Austria
Prior art keywords
pct
processes
production
alkyl
image
Prior art date
Application number
AT92918526T
Other languages
English (en)
Inventor
Peter Edward Cross
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE167187T1 publication Critical patent/ATE167187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92918526T 1991-09-14 1992-09-03 Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen ATE167187T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119705A GB9119705D0 (en) 1991-09-14 1991-09-14 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ATE167187T1 true ATE167187T1 (de) 1998-06-15

Family

ID=10701448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92918526T ATE167187T1 (de) 1991-09-14 1992-09-03 Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Country Status (31)

Country Link
US (1) US5543419A (de)
EP (1) EP0603229B1 (de)
JP (2) JP2672030B2 (de)
KR (1) KR0135784B1 (de)
CN (1) CN1037269C (de)
AT (1) ATE167187T1 (de)
AU (1) AU659487B2 (de)
BR (1) BR9206499A (de)
CA (1) CA2116356C (de)
CZ (1) CZ281752B6 (de)
DE (1) DE69225897T2 (de)
DK (1) DK0603229T3 (de)
EG (1) EG20072A (de)
ES (1) ES2116343T3 (de)
FI (1) FI114707B (de)
GB (1) GB9119705D0 (de)
GR (1) GR3027667T3 (de)
HU (1) HU220594B1 (de)
IL (1) IL103078A (de)
MX (1) MX9205221A (de)
MY (1) MY108602A (de)
NO (1) NO305397B1 (de)
NZ (1) NZ244324A (de)
PL (1) PL170627B1 (de)
PT (1) PT100863B (de)
RU (1) RU2117669C1 (de)
SG (1) SG50414A1 (de)
TW (1) TW251285B (de)
UA (1) UA42686C2 (de)
WO (1) WO1993006098A1 (de)
ZA (1) ZA926939B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2147889T3 (es) 1996-01-19 2000-10-01 Lonza Ag Metodo para preparar 3-hidroxiquinuclidinol opticamente activo.
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
DE69833665T2 (de) 1997-08-08 2006-11-09 Duke University Zusammensetzungen zur vereinfachung von chirurgischen verfahren
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
RU2296762C2 (ru) * 2000-12-22 2007-04-10 Альмиралль Продесфарма Аг Карбаматы хинуклидина, способы их получения и фармацевтическая композиция на их основе
DK1353919T3 (da) 2000-12-28 2006-11-20 Almirall Prodesfarma Ag Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
DE102004057995A1 (de) * 2004-12-01 2006-06-08 Wacker Chemie Ag Verfahren zur Herstellung von α,α-Dialkyl-α-Hydroxymethyl-Carbonsäurederivaten
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
US20100112061A1 (en) * 2006-12-13 2010-05-06 William Baker Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators

Also Published As

Publication number Publication date
PL170627B1 (en) 1997-01-31
JP2672030B2 (ja) 1997-11-05
PT100863A (pt) 1993-10-29
SG50414A1 (en) 1998-07-20
UA42686C2 (uk) 2001-11-15
HU220594B1 (hu) 2002-03-28
PT100863B (pt) 1999-07-30
FI941170L (fi) 1994-03-11
TW251285B (de) 1995-07-11
CZ281752B6 (cs) 1997-01-15
CN1037269C (zh) 1998-02-04
GB9119705D0 (en) 1991-10-30
MX9205221A (es) 1993-03-01
AU2482392A (en) 1993-04-27
DE69225897T2 (de) 1998-10-15
RU2117669C1 (ru) 1998-08-20
FI114707B (fi) 2004-12-15
WO1993006098A1 (en) 1993-04-01
JPH09315970A (ja) 1997-12-09
CA2116356A1 (en) 1993-04-01
EP0603229A1 (de) 1994-06-29
BR9206499A (pt) 1995-11-21
FI941170A0 (fi) 1994-03-11
KR0135784B1 (ko) 1998-04-23
HU9400729D0 (en) 1994-06-28
NO940905D0 (no) 1994-03-14
NZ244324A (en) 1993-12-23
NO940905L (no) 1994-03-14
JPH06510991A (ja) 1994-12-08
IL103078A (en) 1996-07-23
US5543419A (en) 1996-08-06
HUT66772A (en) 1994-12-28
EG20072A (en) 1999-06-30
NO305397B1 (no) 1999-05-25
ZA926939B (en) 1994-03-11
EP0603229B1 (de) 1998-06-10
DE69225897D1 (de) 1998-07-16
AU659487B2 (en) 1995-05-18
CA2116356C (en) 1998-03-31
IL103078A0 (en) 1993-02-21
MY108602A (en) 1996-10-31
DK0603229T3 (da) 1998-10-12
CN1070911A (zh) 1993-04-14
ES2116343T3 (es) 1998-07-16
GR3027667T3 (en) 1998-11-30
JP2955533B2 (ja) 1999-10-04
CZ395392A3 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
ATE167187T1 (de) Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GR3034769T3 (en) Triazole antifungal agents.
ATE192143T1 (de) Substituierte 2,2-dimethyl-omega-phenoxysäure und ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE90676T1 (de) Dioxyalkylenaryl-dihydropyridine zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung.
KR960704536A (ko) 안트라사이클리논 유도체 및 유전분증에서의 이의 용도(Anthracyclinone derivatives and their use in amyloidosis)
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE59209327D1 (de) 2- 3-(4-amidino-phenyl)]-propionsäurederivate, ihre herstellung und verwendung
ATE202704T1 (de) Verwendung eines natrium- oder lysiniumsalzes von crotonsäureamidderivaten zur herstellung eines arzneimittels zur behandlung von krebserkrankungen
ATE113958T1 (de) Organische ester der alkoholischen derivate der 19-nor-steroide und die salze davon, verfahren zu deren herstellung und zwischenprodukte davon, ihre verwendung als arzneimittel und pharmazeutische präparate davon.
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE59310044D1 (de) Imidazolylphenolderivate, diese enthaltende Arzneimittel sowie ein Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
ATE112267T1 (de) Diacylglycerol-nicotinate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE159517T1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
SE9401965D0 (sv) New compounds
ATE165599T1 (de) Benzospiroalken-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
GB2273706B (en) Fused isoxazolidine derivatives and their use in pharmaceutical compositions
ATE72236T1 (de) Neue 9-substituierte carbacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
HU912862D0 (en) Process for producing pharmaceutical compositions comprising substituted 2-cyclohexene derivatives
ATE281453T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE59309487D1 (de) Isoxazolcarbonsäureamide, verfahren zu ihrer herstellung und ihre verwendung
ATE181331T1 (de) Salmycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
SE8401064L (sv) Nya isoxazoler och forfarande for framstellning derav

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee